Mesothelin-specific CD8(+) T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patients. [electronic resource]
Producer: 20040824Description: 297-306 p. digitalISSN:- 0022-1007
- Antigen-Presenting Cells -- physiology
- CD8-Positive T-Lymphocytes -- immunology
- Cancer Vaccines -- immunology
- Cell Line
- GPI-Linked Proteins
- Granulocyte-Macrophage Colony-Stimulating Factor -- metabolism
- HLA-A2 Antigen -- analysis
- HLA-A3 Antigen -- analysis
- Humans
- Hypersensitivity, Delayed -- etiology
- Membrane Glycoproteins -- immunology
- Mesothelin
- Pancreatic Neoplasms -- immunology
- Vaccination
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.